FDA داروی برجسته سرطان لوزالمعده را تأیید می کند که نشان داده شده است بقا را بهبود می بخشد

FDA approves landmark pancreatic cancer drug that's shown to improve survival

U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly form of cancer, by blocking a protein that fuels tumor growth in the vast majority of cases.